Mixing Suboxone and alcohol produces compounding central nervous system (CNS) depression that significantly increases the risk of respiratory failure, overdose, and death. Both substances suppress breathing independently — combined, their effects multiply rather than simply add. Understanding this interaction is essential for anyone in medication-assisted treatment (MAT) for opioid use disorder, as well as their families and care teams.
Key Takeaways
- Respiratory depression doubles: Alcohol intensifies buprenorphine’s CNS-depressant effects, dramatically slowing breathing — the primary mechanism of overdose death
- No safe amount of alcohol: Even moderate drinking while taking Suboxone raises overdose risk; there is no established “safe” threshold
- Naloxone is partially protective: Suboxone contains naloxone to block injection misuse, but it does not reverse alcohol’s sedative effects
- Mixing signals deeper issues: Co-occurring alcohol use during MAT often indicates an underlying alcohol use disorder (AUD) that requires integrated treatment
- Treatment works: Concurrent opioid use disorder (OUD) and AUD respond well to integrated programs combining MAT with evidence-based behavioral therapies like Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT)
- Withdrawal complicates the picture: Alcohol withdrawal can be medically dangerous on its own — managing it alongside opioid dependence requires clinical supervision
- Luxury residential care is available: For those struggling with both substances, structured inpatient treatment in a supervised environment is the safest path forward
If you or someone you care about is mixing alcohol and Suboxone, call Refine Recovery now at (866) 890-9573.
What Is Suboxone and How Does It Work?
Suboxone is a prescription medication used in MAT for opioid use disorder. It contains two active ingredients: buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist added to deter misuse by injection.
Buprenorphine binds to opioid receptors in the brain, reducing withdrawal symptoms and cravings without producing the intense euphoria of full opioid agonists like heroin or oxycodone. This “ceiling effect” makes it safer than methadone at higher doses, but it does not eliminate CNS depressant activity. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), buprenorphine is highly effective when used as prescribed within a comprehensive treatment plan.
Why Alcohol and Suboxone Are a Dangerous Combination
| Substance | CNS Effect | Primary Overdose Risk |
|---|---|---|
| Buprenorphine (Suboxone) | Partial opioid agonist — slows breathing | Respiratory depression |
| Alcohol | GABA-A receptor agonist — slows CNS broadly | Respiratory depression, aspiration |
| Combined | Synergistic CNS suppression | Dramatically elevated overdose and death risk |
| Benzodiazepines (if also present) | Additional CNS depression | Highest-risk polysubstance combination |
Alcohol primarily works by enhancing activity at GABA-A receptors, which inhibits CNS activity. Buprenorphine suppresses the respiratory drive through opioid receptors. When both are active simultaneously, the result is synergistic depression — meaning the combined effect is greater than the sum of each substance alone.
This is why the FDA has issued black box warnings about combining opioids, including buprenorphine, with alcohol and other CNS depressants. Black box warnings represent the FDA’s most serious safety advisory.
Signs of a Suboxone and Alcohol Overdose
Recognizing an overdose is a life-saving skill. The warning signs of combined Suboxone and alcohol toxicity include:
- Slowed or stopped breathing — fewer than 12 breaths per minute, or breathing that pauses entirely
- Extreme sedation — the person cannot be woken up, even with loud noise or physical stimulation
- Blue or grayish lips and fingertips (cyanosis) — indicates oxygen deprivation
- Pinpoint pupils — a classic opioid overdose sign that may still appear even with alcohol present
- Limp body and loss of muscle tone
- Gurgling or choking sounds — signals the airway may be compromised
If you observe these signs, call 911 immediately. Administer naloxone (Narcan) if available — it can partially reverse buprenorphine’s opioid effects, though it will not address alcohol’s contribution to sedation. Stay with the person until emergency services arrive.
Factors That Increase Risk
Several individual variables affect how dangerous the combination becomes for a specific person.
| Risk Factor | Why It Matters | Clinical Significance |
|---|---|---|
| Suboxone dose | Higher doses of buprenorphine intensify CNS depression | Dose-dependent respiratory risk |
| Amount of alcohol consumed | More alcohol = greater synergistic effect | No safe minimum established |
| Body weight and metabolism | Lower body weight = higher blood concentrations | Women typically at greater risk per drink |
| Liver function | Both substances are hepatically metabolized | Impaired liver = slower clearance, prolonged exposure |
| Polypharmacy | Benzodiazepines, sleep aids, or antihistamines compound risk | Triple combinations are especially dangerous |
| Tolerance history | People with low opioid tolerance are more vulnerable | Newly started MAT = highest risk window |
| Age | Older adults clear both substances more slowly | Elderly patients require extra monitoring |
People with co-occurring liver disease face compounded risk because both buprenorphine and alcohol are metabolized by the liver. Impaired liver function slows elimination and prolongs the window of dangerous blood concentrations.
Co-Occurring Alcohol Use Disorder and Opioid Use Disorder
Many people prescribed Suboxone have a history of alcohol use disorder (AUD) alongside opioid use disorder (OUD). These conditions frequently co-occur — research published by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) indicates that people with one substance use disorder are significantly more likely to develop another.
Drinking while on Suboxone is sometimes a sign that alcohol has become its own separate problem — not simply a lapse in the context of opioid recovery. When alcohol use continues or escalates during MAT, it typically signals that a dual diagnosis approach is needed: treatment that addresses both disorders simultaneously rather than sequentially.
At Refine Recovery, integrated dual diagnosis treatment is a core part of how we approach complex cases. Our clinical team addresses the full picture of a person’s substance use history, including co-occurring AUD and OUD, within a structured residential setting.
Why Integrated Treatment Is the Right Approach
Treating OUD and AUD in isolation — attempting to stabilize opioid use while ignoring active alcohol use — consistently underperforms compared to integrated care. Both conditions share overlapping neurobiological mechanisms, including dysregulated reward pathways, impulse control deficits, and stress-response abnormalities.
Effective integrated treatment typically includes:
- Continued buprenorphine or alternative MAT if clinically indicated, with careful monitoring
- Medically supervised alcohol detox — alcohol withdrawal can cause seizures and requires medical management, making self-detox dangerous
- Evidence-based behavioral therapies including CBT, DBT, and relapse prevention therapy
- Family therapy to rebuild the support network and address relationship damage from active addiction
- Aftercare planning to support sustained recovery after discharge
Alcohol Detox During MAT: What to Expect
For people who have been drinking heavily while on Suboxone, alcohol detox is typically the first clinical priority before other treatment elements begin. Alcohol withdrawal syndrome (AWS) can range from uncomfortable to life-threatening, with the most severe form — delirium tremens (DTs) — carrying a mortality risk if untreated.
Medically supervised detox provides close monitoring, symptom management, and medication (typically benzodiazepines or phenobarbital under clinical supervision) to safely manage withdrawal. At Refine Recovery, our path to detox includes on-site medical staff and licensed clinicians to guide each client through this process safely.
Suboxone and Alcohol: Impact on Treatment Outcomes
Continued alcohol use during MAT is one of the strongest predictors of poor treatment outcomes. Alcohol use is associated with:
- Reduced Suboxone effectiveness — alcohol-related impairment undermines the cognitive benefits of MAT and makes behavioral therapy less effective
- Higher risk of opioid relapse — disinhibition from alcohol lowers the threshold for impulsive opioid use
- Increased medical complications — liver damage, cardiovascular stress, and nutritional deficiencies
- Greater social destabilization — alcohol use tends to erode employment, housing, and family stability that support sustained recovery
Addressing alcohol use is not peripheral to opioid treatment — it is central to it.
The Role of Residential Treatment
For individuals mixing Suboxone and alcohol, outpatient treatment often lacks the structure and monitoring needed to achieve stabilization. Residential inpatient treatment removes the person from the environment where drinking and drug use occur, provides 24-hour clinical support, and creates the conditions for genuine behavioral change.
Refine Recovery’s luxury residential program in Los Angeles provides a private, resort-style environment where clients receive individualized clinical care, group therapy, holistic wellness programming, and dedicated case management. Our approach is designed for people who need comprehensive care — not a one-size-fits-all protocol.
Frequently Asked Questions
Can you drink alcohol at all while on Suboxone? There is no established safe amount. Even moderate alcohol use while taking buprenorphine increases the risk of respiratory depression and overdose. Most prescribers advise complete abstinence from alcohol during Suboxone treatment.
Does Suboxone help with alcohol cravings? Buprenorphine is not FDA-approved to treat AUD. Some research suggests it may have modest off-label effects on alcohol cravings, but it is not a substitute for evidence-based AUD treatment. People with both OUD and AUD need integrated treatment addressing both conditions.
What should I do if I drank while on Suboxone? Tell your prescribing provider honestly. If you feel sedated, dizzy, or have slowed breathing, seek emergency care immediately. Ongoing alcohol use while on Suboxone is a clinical signal that your treatment plan needs adjustment — not a reason to stop MAT.
Will Suboxone show up on a drug test? Standard 5-panel drug tests typically do not screen for buprenorphine, but expanded panels used in MAT programs often do. Your prescribing provider may test for buprenorphine to confirm adherence, and for other substances including alcohol to monitor safety.
Can I get treatment for both alcohol and opioid use at the same rehab? Yes. Integrated dual diagnosis treatment for co-occurring OUD and AUD is available at specialized facilities like Refine Recovery. Integrated care consistently outperforms treating each disorder in isolation.
Getting Help for Suboxone and Alcohol Use
Mixing Suboxone and alcohol is not a minor risk — it is one of the most dangerous substance combinations a person can encounter. If this combination has become part of your life, or the life of someone you love, professional treatment within a structured residential setting is the most effective path forward.
Refine Recovery offers comprehensive addiction treatment in Los Angeles and Sherman Oaks, including medically supervised detox, dual diagnosis care, and luxury residential treatment for adults ready to build lasting recovery. Our admissions team is available now to answer questions about your situation, verify insurance, and help you take the next step.
Call (866) 890-9573 or visit our admissions page to get started today.
